Some benefits of increased GLP-1 secretion in DM2 patients are an improvement in insulin–glucagon ratio, suppression of endogenous glucose production and the increase in first-pass splanchnic glucose uptake [47,58]. This evidence concerns the gene INS and myotonic dystrophy type 2.